Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Lymphoma / Leukemia / Myeloma News

Socioeconomic Status Plays Role In Whether Patients Receive Appropriate Treatment For Non-Hodgkin Lymphoma, Study Finds

Main Category: Lymphoma / Leukemia / Myeloma
Also Included In: Public Health
Article Date: 23 Oct 2008 - 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Socioeconomic factors such as income and education appear to affect whether people with non-Hodgkin lymphoma receive appropriate treatment, according to a study in the journal Cancer, Reuters reports. While mortality from the disease was higher among blacks, the gap disappeared after researchers accounted for socioeconomic status. According to the researchers, no other studies have examined racial differences in mortality from non-Hodgkin lymphoma.

For the study, Xianglin Du of the University of Texas School of Public Health and colleagues examined 13,321 Medicare beneficiaries ages 65 and older who were diagnosed with non-Hodgkin lymphoma between 1992 and 1999. The study population included 11,868 whites, 533 blacks and 920 people of other races and ethnicities. About 72% of the black patients and 22% of white patients were in the lowest income category, and blacks also were more likely than whites to have a lower level of education.

According to the study, 43% of blacks and 52% of whites received chemotherapy, the standard treatment for non-Hodgkin lymphoma. In addition, 18% of blacks and 24% of whites received radiation treatment, which is recommended for some patients with the disease. Patients' socioeconomic status and whether they received chemotherapy affected survival, according to the study. For patients receiving chemotherapy, the average survival period was 32.5 months, compared with 11.9 months for those who did not receive the treatment, the study found.

Du said that every non-Hodgkin lymphoma patient should receive appropriate treatment. Du also said that boosting overall education levels could help ensure that people with non-Hodgkin lymphoma are diagnosed earlier and treated appropriately. Those with less education or lower incomes might not be as able as others to cover out-of-pocket costs and have insurance, Du said (Harding, Reuters, 10/21).

An abstract of the study is available online.

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation.  All rights reserved.




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Chemotherapy? What Are The Side Effects Of Chemotherapy?
22 Jul 2009
Chemotherapy is the use of chemicals (medication) to treat disease - more specifically, it usually refers to the destruction of cancer cells. However, chemotherapy also includes the use of antibiotics or other medications to treat any disease...


CML Therapy Side Effects image CML Therapy Side Effects

Even "targeted" therapy for chronic myeloid leukemia is not without side effects. Some, like low blood counts, are serious. Hear how one patient, along with her oncologist, Dr. Neil Shah of UCLA, managed the side effects of her CML treatment...

Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

View more videos...